Loxiglumide
CAS No. 107097-80-3
Loxiglumide ( CR-1505; Loxiglumide, brand name: Loxizin. )
产品货号. M17793 CAS No. 107097-80-3
Loxiglumide is a cholecystokinin (CCK-1) receptor antagonist.
纯度: 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥275 | 有现货 |
|
10MG | ¥462 | 有现货 |
|
25MG | ¥964 | 有现货 |
|
50MG | ¥1920 | 有现货 |
|
100MG | ¥3378 | 有现货 |
|
500MG | ¥7679 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Loxiglumide
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Loxiglumide is a cholecystokinin (CCK-1) receptor antagonist.
-
产品描述Loxiglumide is a potent, orally active, and selective CCK-A receptor antagonist which stimulates calorie intake and hunger feelings in humans. Loxiglumide inhibits pancreatic secretion of digestive enzymes, and also blocks CCK-induced gastric secretions and emptying. Intravenous administration of loxiglumide antagonized the CCK-induced reduction of gastric emptying in rats, acceleration of intestinal transport in mice, increase in ileal motility in rabbits, gallbladder contraction in guinea pigs and acceleration of gallbladder emptying in mice.
-
同义词CR-1505; Loxiglumide, brand name: Loxizin.
-
通路Others
-
靶点Other Targets
-
受体CCK
-
研究领域——
-
适应症——
化学信息
-
CAS Number107097-80-3
-
分子量461.38
-
分子式C21H30Cl2N2O5
-
纯度98%
-
溶解度DMSO : ≥ 150 mg/mL; 325.11 mM
-
SMILESCCCCCN(CCCOC)C(=O)C(CCC(=O)O)NC(=O)c1cc(c(cc1)Cl)Cl
-
化学全称4-(3,4-dichlorobenzamido)-5-((3-methoxypropyl)(pentyl)amino)-5-oxopentanoic acid
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Teyssen S, et al. Pancreas. 1996 Nov;13(4):407-16.2. Shiratori K, et al. Pancreas. 2002 Jul;25(1):e1-5.
产品手册
关联产品
-
Methyl nomilinate
Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.
-
Oxindole
Oxindole is an aromatic heterocyclic building block.?2-indolinone derivatives have become lead compounds in the research of kinase inhibitors.Oxindole structure has been used in receptor tyrosine kinases (RTKs) inhibitors such as SU4984 and intedanib, the RTK family represents an important therapeutic target for anti-cancer drug development.
-
Methyl nomilinate
Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.